Compile Data Set for Download or QSAR
Report error Found 24 Enz. Inhib. hit(s) with all data for entry = 11766
TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645606(US20240018124, Compound 21)
Affinity DataIC50: 100nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645612(US20240018124, Compound 27)
Affinity DataIC50: 550nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645623(US20240018124, Compound 44)
Affinity DataIC50: 550nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645621(US20240018124, Compound 41)
Affinity DataIC50: 550nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645619(US20240018124, Compound 39)
Affinity DataIC50: 550nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645618(US20240018124, Compound 38)
Affinity DataIC50: 550nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645617(US20240018124, Compound 37)
Affinity DataIC50: 550nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645616(US20240018124, Compound 33)
Affinity DataIC50: 550nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645613(US20240018124, Compound 28)
Affinity DataIC50: 550nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645600(US20240018124, Compound 1)
Affinity DataIC50: 550nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645610(US20240018124, Compound 25)
Affinity DataIC50: 550nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645607(US20240018124, Compound 22)
Affinity DataIC50: 550nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645605(US20240018124, Compound 20)
Affinity DataIC50: 550nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645604(US20240018124, Compound 19)
Affinity DataIC50: 550nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645602(US20240018124, Compound 9)
Affinity DataIC50: 550nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645601(US20240018124, Compound 6)
Affinity DataIC50: 550nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645611(US20240018124, Compound 26)
Affinity DataIC50: 1.30E+4nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645609(US20240018124, Compound 24)
Affinity DataIC50: 1.30E+4nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645608(US20240018124, Compound 23)
Affinity DataIC50: 1.30E+4nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645614(US20240018124, Compound 30)
Affinity DataIC50: 1.30E+4nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645615(US20240018124, Compound 32)
Affinity DataIC50: 1.30E+4nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645603(US20240018124, Compound 16)
Affinity DataIC50: 1.30E+4nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645620(US20240018124, Compound 40)
Affinity DataIC50: 1.30E+4nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetfMet-Leu-Phe receptor(Human)
Biofront

US Patent
LigandPNGBDBM645622(US20240018124, Compound 43)
Affinity DataIC50: 1.30E+4nMAssay Description:Cyclic Adenosine Monophosphate (cAMP) Assay: CHO-K1 cells stably overexpressing hFPR1 were plated into 384-well cell culture plates (2,000/well/5 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent